Inspire Medical Systems, Inc. Common Stock (NY:INSP)

70.27 -1.22 (-1.71%)

Delayed Quote Updated: 12:41 PM EDT, Oct 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inspire Medical Systems, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

3 Cash-Heavy Stocks We Steer Clear Of

October 08, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...

Via StockStory

Topics Retirement

1 Profitable Stock Worth Your Attention and 2 We Ignore

October 06, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Topics Supply Chain

Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines

October 04, 2026

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including In...

Via StockStory

1 Momentum Stock to Target This Week and 2 That Underwhelm

September 22, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

Topics Artificial Intelligence Electric Vehicles Energy

Why Inspire Medical Systems (INSP) Stock Is Up Today

September 11, 2026

What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 7.4% in the morning session after Stifel analyst Jonathan Bloc...

Via StockStory

Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q2 Earnings?

September 04, 2026

Inspire Medical Systems currently trades at $62.14 per share and has shown little upside over the past six months, posting a small loss of 3.4%. The stock al...

Via StockStory

Topics Supply Chain

3 Cash-Producing Stocks That Concern Us

August 25, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

August 24, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

Via StockStory

Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks

August 20, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Haemonetics (NYSE:HAE) and it...

Via StockStory

1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges

August 20, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript ↗

August 10, 2026

Revenue fell 7.6% on coding disruptions, but management raised full-year guidance.

Via The Motley Fool

Topics Earnings Economy

5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call

August 10, 2026

Inspire Medical Systems’ second quarter results were marked by improved coding clarity and cost discipline, which management credited as key drivers behind t...

Via StockStory

Topics Earnings

1 Cash-Heavy Stock with Exciting Potential and 2 We Question

August 10, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

Via StockStory

Why Are Inspire Medical Systems (INSP) Shares Soaring Today

August 04, 2026

What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 18.3% in the morning session after the company reported an imp...

Via StockStory

Topics Earnings Economy

Inspire Medical Systems Q2 Earnings Call Highlights ↗

August 03, 2026

Inspire Medical Systems (NYSE:INSP) reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The...

Via MarketBeat

Topics Earnings

Stay updated with the stocks that are on the move in today's after-hours session. ↗

August 03, 2026

Via Chartmill

Inspire Medical Systems (NYSE:INSP) Reports Bullish Q2 CY2026, Stock Jumps 13.6%

August 03, 2026

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 7.6%...

Via StockStory

Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors

August 03, 2026

From Mobia Medical, Inc.

Via GlobeNewswire

What To Expect From Inspire Medical Systems’s (INSP) Q2 Earnings

August 01, 2026

Medical technology company Inspire Medical Systems (NYSE:INSP) will be announcing earnings results this Monday after the bell. Here’s what to expect. Inspire...

Via StockStory

1 Profitable Stock on Our Buy List and 2 Facing Challenges

July 31, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

July 24, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

3 Medical Device Stocks Giving Investors a Different Healthcare Play ↗

July 20, 2026

Globus Medical, Inspire Medical Systems, and Penumbra show varied revenue growth and analyst ratings, offering medical device investors alternatives to traditional pharmaceutical stocks.

Via MarketBeat

3 High-Flying Stocks We Steer Clear Of

July 15, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...

Via StockStory

2 Reasons INSP is Risky and 1 Stock to Buy Instead

July 09, 2026

Shareholders of Inspire Medical Systems would probably like to forget the past six months even happened. The stock dropped 49.8% and now trades at $49.36. Th...

Via StockStory

Topics Supply Chain

1 Russell 2000 Stock to Target This Week and 2 Facing Challenges

July 08, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Via StockStory

Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

June 29, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

3 Cash-Producing Stocks We Think Twice About

June 29, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Via StockStory

1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down

June 23, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...

Via StockStory

Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 11, 2026

Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?

Via The Motley Fool

3 Stocks Under $50 We Steer Clear Of

June 04, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.